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Summary
Objective: In vivo imaging of cartilage degeneration in small animal models is nowadays practically impossible. In the present study, we
investigated the use of micro-computed tomography (mCT) in combination with a negatively charged ionic iodine dimer (ioxaglate) for in vivo
assessment of cartilage degeneration in a small animal model.
Methods: Cartilage degeneration was induced in the right knee of rats by injection of mono-iodoacetate (MIA). We imaged the rat knees with
ioxaglate enhanced mCT-arthrography at 4, 16 and 44 days after MIA injection. Subsequently, mCT-arthrographic ﬁndings were evaluated and
compared with quantitative histology of the patellar cartilage.
Results: In vivo mCT-arthrography clearly detected cartilage degeneration in the rat knee-joints, in which the ioxaglate diffused into the degen-
erated cartilage layer. Higher mCT-attenuation values and smaller total volumes of the cartilage layer were detected at longer time periods after
MIA injection, which is quantitatively conﬁrmed by histology.
Conclusion: In vivo mCT-arthrography is a valuable tool for detection of minor cartilage alterations and distinguishes different stages of car-
tilage degeneration in a small animal model. Since mCT, at the same time, also visualizes osteophyte formation and changes in the underlying
subchondral bone structures, the technique will be very useful for longitudinal overall assessment of the development of (osteo)arthritis and to
study interventions in small animal models.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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A great need exists for improved imaging of cartilage
degeneration in both humans and (small) animal models,
to enable the development of novel therapies for treatment
of degenerative joint diseases. Several small animal models
have been developed to study degenerative joint diseases,
such as osteoarthritis1e6 or rheumatoid arthritis7e9. In
general, the evaluation of cartilage in such animal models
is performed in a cross-sectional manner by histological
scoring5. In vivo longitudinal evaluation of cartilage
degeneration in these models would be useful for studying
degenerative joint disease and development of novel
therapies.
Micro-computed tomography (mCT) is a high resolution
imaging modality which has the potential to accurately
image subchondral bone changes and thereby follow
disease progression of osteoarthritis in small animal models
such as mice and rats10e12. A limitation of mCT is its inferior
soft tissue contrast, so cartilage cannot be imaged directly
with this modality. mCT-arthrography offers the possibility*Address correspondence and reprint requests to: Dr Harrie
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1011of indirect visualization of cartilage morphology by injection
of a radio-opaque contrast agent into the joint cavity. This
technique has been demonstrated ex vivo13.
A few attempts have been made to use mCT for in vitro
visualization of cartilage morphology13,14 as well as for
cartilage glycosaminoglycan (GAG) content by using
negatively charged ionic contrast agents14,15. The latter
technique is based on the interaction of negatively charged
ionic iodated radio-opaque molecules with the cartilage
negative ﬁxed charged density. It is theoretically similar to
the delayed gadolinium enhanced magnetic resonance
imaging of cartilage (dGEMRIC) technique16e18. The ﬁxed
charge density is determined by the negatively charged
GAG molecules, which are attached to the cartilage proteo-
glycans. Negatively charged contrast molecules can enter
the cartilage matrix at sites where GAG depletion occurs,
in this manner can visualize sites of GAG depletion.
Despite the possibility to image morphology and
biochemical composition of cartilage with mCT, there are
no reports of mCT imaging of cartilage in vivo. This may
be due to external factors that hamper in vivo-arthrogra-
phy, such as leakage of contrast-dye out of the joint cavity
and the long time period it takes for the articular cartilage
to become saturated with contrast agent14. The aim of this
study was to solve these external problems and test the
capabilities of mCT in combination with a negatively
charged ionic iodine dimer (ioxaglate) for in vivo assess-
ment of cartilage degeneration in a small animal model
for osteoarthritis.
Fig. 1. (A) Representation of selection of the different ROIs from the mCT-arthrogram (transversal plane), 1: ROI for determination of ioxaglate
diffusion into the cartilage matrix. 2: ROI for determination of ioxaglate leakage out of joint cavity 3: ROI for selection of the total cartilage used
for determination of cartilage volume and mean attenuation. (B) Representation of the manual selection of the patellar cartilage layer from the
histological sections.
1012 T. M. Piscaer et al.: mCT imaging of cartilage degenerationMaterials and methodsEXPERIMENTAL ANIMAL MODELAll procedures were approved by the animal ethical committee of the
Erasmus Medical Centre, Rotterdam, The Netherlands (EUR. 874). Cartilage
degeneration was induced in the right knees of 14 weeks old male Wistar
rats (n¼ 12) (Harlan, Horst, the Netherlands) by intra-articular injection of
1 mg sodium mono-iodoacetate (MIA) (Sigma-Aldrich) dissolved in 50 mlFig. 2. mCT-arthrogram of a rat knee at different sections. (A and B) Sagit
bone structures of the knee. (C) Coronal plane, showing the posterior par
inferior part of the knee with smsterile saline. As a control, an equal amount of saline was administered
into the left knee19.mCT-ARTHROGRAPHYFor mCT-arthrography we used the contrast-dye Hexabrix320 (Mallinck-
rodt, Hazelwood, MO, USA). Hexabrix320 is a radio-opaque dye which
is a 600 mOsm solution of the salts ioxaglateemeglumine andtal plane, showing non-calciﬁed cartilage, meniscus, ligaments, and
t of the knee with its structures. (D) Transversal plane, showing the
all ligamentous structures.
Fig. 3. Representative histological sections with their corresponding
mCT-arthrography slices of the patellae of saline injected and MIA
injected knees, 4, 14 and 44 days after injection. Histological
sections are double stained with a Von Kossa staining showing
the calciﬁed tissue (browneyellow) and a thionine staining showing
the GAG containing cartilage (purple).
1013Osteoarthritis and Cartilage Vol. 16, No. 9ioxaglateesodium. Ioxaglate is a radio-opaque negatively charged ionic
iodated dimer with an attenuation-ratio of three. The negatively charged
ioxaglate will be locally repulsed by the negative ﬁxed charge density of
the cartilage, which results from the local GAG content. This means that
ioxaglate penetration into the cartilage results in a concentration that is
inversely related to the GAG content14,20.PROCEDUREThe rat was brought under isoﬂurane anesthesia; breathing pattern and
temperature were monitored continuously. The knee of the rat was shaved
and sterilized with povidon-iodine. Non-diluted Hexabrix320 (100 ml) was
injected into the knee cavity using a 0.5 ml, 27 gauche needle (Sherwoode
Davis & Geck, Gosport, UK). The Hexabrix320 was mixed with 0.005 mg
epinephrine (Centrafarm, Etten-Leur, The Netherlands) to induce
vasoconstriction and thereby prevent leakage of the ioxaglate out of the
knee-cavity21. The joint was mobilized passively to distribute the contrast
agent throughout the joint cavity. Subsequently the hind paw was mounted
in a holder with the knee in extension. mCT scans were made using a Skyscan
1076 in vivo mCT scanner (Skyscan, Belgium). Scanning duration was 15 min
per knee at an isotropic voxelsize of 35 mm (55 kV, 177 mA, ﬁeld of view
35 mm). All scans were performed using the same scan-settings and scan
data were reconstructed in an exact same way such that calculated
volumes and mean attenuation values could be compared between the
different scans.
A mCT-arthrogram of each knee was obtained at 4 days (n¼ 2, group 1),
16 days (n¼ 5, group 2) or 44 days (n¼ 5, group 3) after intra-articular
injection of MIA.Additionally, to monitor the kinetics of ioxaglate transport into cartilage
and out of the knee cavity, a time-series of mCT scans was made with
different time intervals up to approximately 350 min after Hexabrix320
injection. The time-series was obtained from both knees of one animal
from group 1, two animals from group 2 and two animals from group 3.CONTRAST-DYE KINETICSTo measure ioxaglate diffusion into the cartilage matrix and its leakage
out of the knee cavity, changes in mCT-attenuation were followed over
time in ﬁve animals (10 knee-joints). Two regions of interest (ROIs) were
chosen in the intra-cavital knee space and the cartilage [Fig. 1(A)]. Different
scans of the time-series of each knee were reoriented in three dimensions to
match the ﬁrst scan using image registration techniques22, enabling to match
the ROIs in the successive scans.
Mean attenuation values were evaluated in the successive scans to follow
the kinetics of the ioxaglate ions using Skyscan mCT-analysis software
(Skyscan).
The ﬁrst scans of the time-series (immediately after contrast-dye injection)
proved to have best discrimination capabilities between normal and degen-
erated cartilage (see Results). These scans were used for further analysis.CARTILAGE VOLUME AND ATTENUATIONFor all animals (n¼ 12, 24 knee-joints) the cartilage was selected by
drawing a ROI through the subchondral bone and the intra-cavital
ioxaglate, including all the patellar cartilage [Fig. 1(A)]. The patellar cartilage
was segmented using one ﬁxed threshold for all scans that was selected vi-
sually. Segmented volumes and mean mCT-attenuation values of the carti-
lage were calculated (3D) using Skyscan analysis software (Skyscan).
Since ioxaglate ions diffuse into the cartilage matrix, the ioxaglateecarti-
lage interface becomes blurred what limits accurate segmentation of the
cartilage. To gain insight into the changes in the cartilage without having
to segment ﬁrst, we also obtained cumulative histograms of the attenuation
distribution inside the ROIs.HISTOLOGICAL ASSESSMENTAfter scanning, the animals were sacriﬁced and the patella of each knee
was dissected, ﬁxed in formalin and subsequently imbedded in methylmeta-
crylate. One transversal section of exact 6 mm thickness from the middle part
of the patella was obtained. The sections were double stained: Von Kossa
staining was used to visualize calcium distribution and thereby visualize
the interface between the calciﬁed and non-calciﬁed cartilages. Subse-
quently, the same sections were stained with thionine to image the amount
and distribution of the GAGs. Thionine binds to the negatively charged
sulfate groups of GAGs in cartilage and should provide inverse distribution
to the negatively charged ioxaglate ions23. Sections were stained all at
once, to minimize measurement artefacts. Subsequently, microphotographs
of the sections were obtained, using a digital camera with a constant light in-
tensity. The non-calciﬁed cartilage layer of the patella was manually selected
from the microphotographs [Fig. 1(B)]. Volume and mean staining intensity
(GAG content) from the cartilage sections were determined. These volumes
and intensities were compared to volumes and mCT-attenuation values of the
corresponding mCT-arthrograms. All procedures were performed in a stan-
dardized way to minimize measuring artefacts and enable detection of rela-
tive alterations.ResultsmCT-ARTHROGRAPHYDuring the procedure, the animals had a regular breathing
pattern and a stable temperature. Ioxaglate was distributed
throughout the whole knee cavity in all animals, though at-
tenuation was highest around the patello-femoral joint
(Fig. 2). Ligaments and non-calciﬁed menisci were clearly
visible as low attenuation bands surrounded by ioxaglate
(Fig. 2). Non-calciﬁed cartilage was indirectly visualized as
a band of low attenuation between the calciﬁed tissue and
the ioxaglate in the knee cavity (Fig. 2). The interface be-
tween the cartilage and the intra-cavital ﬂuid was a blurred
region in the MIA injected joints; indicating ioxaglate pene-
tration into the cartilage. This seemed to get more intense
depending on the time after MIA injection (Fig. 3).
Fig. 4. Contrast-dye kinetics over a period of 350 min. Data obtained from the time-series scans, showing the X-ray attenuation values over
time in the different compartments. The curve of the intra-articular ﬂuid in the intra-cavital knee space of the intra-articular ﬂuid (all knees
MIAþ saline injected, n¼ 10) indicates ioxaglate leakage out of the knee space. The curve for the degenerated (MIA, n¼ 5) and healthy
(saline, n¼ 5) cartilage of both MIA (n¼ 5) and saline (n¼ 5) injected knees indicates diffusion of ioxaglate in and out of the cartilage.
mCT-attenuation values of air, cortical bone and full strength Hexabrix320 are visualized with the dotted lines.
1014 T. M. Piscaer et al.: mCT imaging of cartilage degenerationHISTOLOGYThe histological stained sections showed a clear delinea-
tion of the calciﬁed and non-calciﬁed cartilages interface
and a clear delineation of the cartilage from background.
Cartilage of the MIA treated knees showed GAG depletion
(decrease in staining intensity) that was increasing with
time after MIA injection (Fig. 3). Cartilage was present in
all samples and no ﬁssures were found.CONTRAST-DYE KINETICSIoxaglate remained visible in the knee cavity for over
200 min, though mean mCT-attenuation decreased in inten-
sity (Fig. 4). The leakage of ioxaglate was different between
control and MIA treated knees. A remarkable difference was
noticed between the diffusion of ioxaglate into the patellar
cartilage of the control knees and the MIA injected knees.
mCT-attenuation of the patellar cartilage of the control knees
was lower, indicating less diffusion of ioxaglate into the
healthy cartilage. Highest cartilage X-ray attenuation of all
MIA treated knees was detected in the ﬁrst scan, indicating
fast diffusion of the ioxaglate ions in the degenerated patel-
lar cartilage, thus peak mCT-attenuation of degenerated pa-
tellar cartilage must be around 0e20 min post contrast-dye
injection. The cartilage of the control knees gave a continu-
ously low attenuation (Fig. 4).SEGMENTED CARTILAGE, VOLUMESFour days after MIA injection, the volume of the seg-
mented cartilage showed no meaningful changes (n¼ 2).At 16 and 44 days after MIA injection, volume of the seg-
mented cartilage was, respectively, 48% (16%) and 81%
(7%) smaller compared to the segmented cartilage of
the control condition. This was conﬁrmed by a decrease
of the histological assessed cartilage volume of the MIA
injected knee compared to its contra-lateral counterpart by
37% (19%) at day 16 and 55% (13%) at day 44
[Fig. 5(A) and (C)].SEGMENTED CARTILAGE, ATTENUATIONFour days after MIA injection, mean mCT-attenuation of
the segmented cartilage was increased by 15% (8%), indi-
cating GAG depletion. GAG depletion was also apparent
from the histological sections that showed a 16% (10%)
decrease in the mean intensity of the thionine stained
cartilage. At 16 and 44 days after MIA injection the mean
mCT-attenuation increased, respectively, 10% and 19% com-
pared to the control condition. Histology showed a much
larger 47% (9%), respectively, 56% (5%) decrease in
staining intensity at these time points [Fig. 5(B) and (C)].CUMULATIVE HISTOGRAMS OF ATTENUATION/STAINING
INTENSITYA normal distribution of a histogram becomes a sigmoid
(S-) shaped curve in a cumulative histogram. Therefore
a relative shift in the mCT-attenuation/staining intensity
values can be detected clearly from a cumulative histogram.
Cumulative histograms of the MIA treated knees started to
increase at higher mCT-attenuation values than the control
Fig. 5. Quantiﬁcation of segmented cartilage of mCT and histology. (A) Percentage volume change of segmented cartilage of MIA injected
knees over the control condition (contra-lateral side), values of mCT-arthrography and histological obtained data are presented. (B) Percentage
mCT-attenuation and histological staining intensity changes of cartilage from MIA injected over control knees. (C) Three dimensional recon-
structions of patellae with segmented cartilage layer. Note the decrease of segmented cartilage volume over time and adjacent bone erosion
(arrow) at 44 days post MIA injection. (D) mCT-arthrography images in a transversal plane. The patellar cartilage is presented in colors that
resemble the attenuation patterns.
1015Osteoarthritis and Cartilage Vol. 16, No. 9treated knees. This means that the cumulative histograms
of the MIA treated condition contain more pixels at higher
mCT-attenuation values, indicating more ioxaglate and
thus fewer GAGs in the MIA treated cartilage. The cumula-
tive histograms of 4, 16 and 44 days after MIA injection
were shifted to the right, which means that they increased
in pixel volume at higher mCT-attenuation values than the
control cartilage and thus overall contained higher concen-
trations of ioxaglate indicating more GAG depletion (Fig. 4).
The distance that the cumulative histogram shifted de-
pended on the time after MIA injection and was similar in
the cumulative histograms of the mCT and histological
cartilage sections [Fig. 6(A) and (B)].
At high inversed staining intensity values, the cumulative
histograms derived from histology reached a plateau that
represents the total volume of the cartilage. Cumulative his-
tograms of the mCT-arthrograms did not reach this plateau
at high mCT-attenuation values due to interference of
bone and intra-cavital ioxaglate surrounding the cartilage.Discussion
We have shown the capabilities of in vivo mCT-
arthrography for assessment of different stages of cartilage
degeneration in an experimental small animal model for
osteoarthritis. mCT-arthrography proved to be a simple
procedure in which directly after injection of the contrast
agent, a clear distinction could be made between healthy
and degenerative cartilage. This distinction was already
measurable with minimal GAG depletion, 4 days after
injection of MIA.
Besides cartilage degeneration, mCT-arthrography
showed anatomical features of the knees such as ligaments
and non-calciﬁed menisci. Visualization of these anatomical
features might be useful for other experimental animal
models of osteoarthritis, such as the ACL dissection or
medial meniscectomy model2. The articular surfaces of
the femoral and tibial cartilage layers could not be clearly
distinguished in all mCT-arthrograms due to the low amount
Fig. 6. Cumulative histograms of the patellar cartilage. (A) Histograms of the mCT-arthrograms. (B) Histograms of histological sections. Both
histograms show a similar increase in volume with increasing mCT-attenuation (A) or staining intensity (B) depending on the time after MIA
injection. The histological obtained cumulative histograms (B) reach a plateau at high attenuation values which represents the actual cartilage
volume. The cumulative histograms of the mCT-arthrograms do not reach a plateau at the actual cartilage volume due to interference of bone
and intra-cavital ioxaglate attenuation. The relative shift in the attenuation/intensity at 4, 16 and 44 days is similar in mCT and histological
evaluations.
1016 T. M. Piscaer et al.: mCT imaging of cartilage degenerationof ioxaglate concentration between femur and tibia. This
might be due to the position of the animals in the scanner,
since extension of the hind legs caused ﬁxation of the
articular surface of the tibia onto the femur and menisci. A
more ﬂexed position will give wider joint space and might
make it possible to assess the total femoral and tibial
cartilage layers as well.
In a prior attempt of mCT-arthrography in vivo (data not
shown) we noticed extreme fast diffusion of ioxaglate out
of the knee cavity. Ioxaglate remained in the knee-joint
less than 1 min, which is insufﬁcient for performing mCT-
arthrography. To minimize diffusion of ioxaglate out of
the joint cavity we mixed the contrast medium with
epinephrine to acquire adequate vasoconstriction21. The
animal did not respond with changes in breathing pattern
or temperature, probably due to slow diffusion of the
epinephrine into the circulation. However, effects on joint
tissue cannot be excluded and should be investigated in
future studies. It might be possible to lower the dose of epi-
nephrine. Adverse effects of ioxaglate on rats have been
reported after intra-venous injection of the ioxaglate. Intra-
venous administration of a high dose of the contrast agent
causes a transient drop in minute ventilation24. We do not
expect these systemic effects by intra-articular use of the
contrast agent, since the amount of ioxaglate administered
is far less by intra-articular instead of intra-venous adminis-
tration and in combination with the epinephrine it leaks into
the circulation at a slow rate. Furthermore, toxicological
effects on the synovial membrane after intra-articular
administration of ioxaglate have not been found25.
The X-ray dose in this study was approximately 0.5 Gy for
a single scan, we presume that this amount of radiation
causes no effect on the animal tissues as investigated in lon-
gitudinal dose dependent studies on bone in rats. Though, if
scans are performed too frequent, e.g., more than once
a week, the effects of radiation cannot be excluded26.
Due to the diffusion of the ioxaglate out of the knee cavity,
the ioxaglate concentration did not reach an equilibrium
state in the cartilage. This means that the total GAG content
of the cartilage could not be measured by the equilibrium
partitioning method as suggested by Palmer et al.14.
However, the diffusion rate of ioxaglate into the cartilage isalso negatively related to the cartilage ﬁxed charge density
determined by the GAGs27,28. Therefore the current mea-
surements that were made before equilibrium was reached
also contain information about GAG content. Besides the
ﬁxed charge density, tissue density, determined by the colla-
gen and proteoglycan networks cause frictional drag to the
large ioxaglate molecules, which diminishes the diffusion
rate28,29. As a consequence of these two factors, ioxaglate
will diffuse faster into the degenerated cartilage, resulting
in higher concentrations of ioxaglate at an earlier time point
compared to intact cartilage. A third factor that might inﬂu-
ence diffusion rate of ioxaglate into the cartilage is the osmo-
larity of the interstitial ﬂuid of the cartilage matrix. The
osmolarity depends on the concentration of GAG and the in-
tegrity of the collagen matrix. Healthy cartilage osmolarity
ranges over 350e480 mOsm30, if GAG concentration dimin-
ishes or the collagen matrix degrades, the osmolarity falls to
280e350 mOsm depending on the degree of degradation.
For mCT-arthrography we used full strength 600 mOsm Hex-
abrix320, which is hypertonic to healthy cartilage and even
more hypertonic to degenerated cartilage. The intra-articular
injected contrast-dye will have highest afﬁnity for compart-
ments with low osmolarity, thus it will diffuse faster into
more degenerated cartilage. The effect is most pronounced
immediately after intra-articular injection of the Hexabrix320
for its osmolarity will decrease rapidly as a result of contrast-
dye leakage to the bloodstream (280e310 mOsm) and dilu-
tion due to a ﬂuid shift from the bloodstream into the knee
cavity. Together, all these factors increase the sensitivity
of the method for detection of degeneration of cartilage
and might explain why we already could discriminate
between healthy and degenerative cartilage at 4 days after
MIA injection [Figs. 5(B) and 6(B)].
Due to penetration of ioxaglate from the knee cavity into
the cartilage there was a diffuse border between the intra-
cavital ioxaglate and the cartilage, with gradually decreas-
ing attenuation toward the calciﬁed cartilage. This made it
impossible to select the actual cartilage volume using one
attenuation threshold for segmentation. The cumulative
histograms made it clear that segmented volumes would
be highly dependent on the degree of attenuation, which
in turn is dependent on both the actual size of the cartilage
1017Osteoarthritis and Cartilage Vol. 16, No. 9and the diffusion rate of ioxaglate into the cartilage. Thus
mCT-arthrography detects cartilage degeneration as a result
of a decrease of the actual cartilage volume, GAG depletion
and matrix destruction. The actual contribution of each of
these factors cannot yet be determined separately and
has to be investigated further in future studies. However,
the method is highly sensitive to detect general cartilage
degeneration by e.g., analysis of the shift in cumulative
histograms.
Since mCT-arthrography seems suited for sensitive
assessment of cartilage degeneration in small animal
models, translation of this technique for assessment of car-
tilage degeneration in humans might be possible as well.
X-ray- and CT-arthrography are performed in human joints
already for a long time31. As far as we know, the diffusion
rate of contrast into the cartilage has never been reported
as a measure of GAG content of the cartilage. Though,
already in 1977, Roebuck proposed to use the cartilage dif-
fusion rate of the contrast agent dimer X for detection of
sites of cartilage and meniscal damage32. The advantage
of CT over imaging modalities such as MRI, is its availabil-
ity, its low costs and short acquisition time. Furthermore,
clinical CT scanners have a relatively high isotropic resolu-
tion and superior bone contrast. These advantages make
the use of CT in combination with a negatively charged con-
trast agent as a measure of GAG content of the cartilage
very interesting to investigate in future studies.
In conclusion, we showed that in vivo mCT-arthrography
can detect minor cartilage alterations and clearly differenti-
ates different stages of cartilage degeneration. This shows
the potential of the method for longitudinal quantitative 3D
analysis of cartilage in small animal models for (osteo)arthri-
tis. The method can be combined with existing mCTmethods
to analyze bone structures in vivo10 and become an
extremely valuable tool in osteoarthritis intervention studies.Conﬂict of interest
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